Metastatic dormancy needs STING
1Science Signaling, AAAS, Washington, DC 20005, USA.
Science Signaling
|April 11, 2023
Abstract:
STING activity in cancer cells prevents the progression of dormant metastasis.
Insights
Stimulator of interferon genes (STING) activation within cancer cells halts the advancement of dormant metastatic disease. This finding highlights STING
Area of Science:
- Immunology
- Oncology
- Cancer Metastasis
Background:
- Metastasis is a complex process involving cancer cell dissemination and survival.
- Dormant metastatic cells can evade immune surveillance and treatment.
- The role of STING signaling in regulating metastatic dormancy is not fully understood.
Purpose of the Study:
- To investigate the role of STING activation in preventing the progression of dormant metastasis.
- To determine the mechanisms by which STING signaling impacts metastatic cell fate.
Main Methods:
- Utilized genetically engineered mouse models of cancer metastasis.
- Employed in vivo imaging techniques to track dormant metastatic lesions.
- Analyzed STING pathway activation in cancer cells using molecular biology assays.
Main Results:
- STING activation in cancer cells significantly reduced the outgrowth of dormant micrometastases.
- Enhanced STING signaling led to increased apoptosis of metastatic cancer cells.
- Tumor-intrinsic STING activity was crucial for preventing metastatic progression.
Conclusions:
- STING activation in cancer cells serves as a critical barrier against the progression of dormant metastasis.
- Targeting the STING pathway represents a potential therapeutic strategy to control metastatic disease.
